GlassScriptPhysician profile
Daniel Lee Howell
NPI 1235393612
$5,639.11
in general payments reported to CMS, 2019-2025
15 companies · $1,376 in 2025
The $1,376 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,926 · 2020: $103 · 2021: $93.03 · 2022: $85.51 · 2023: $43.36 · 2024: $12.24 · 2025: $1,376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808 · Travel and Lodging: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.56 |
| Travel and Lodging | $624.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $3,904.87 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,024.51 | 2025 | |
| Canon Medical Systems USA, INC. | $200.64 | 2025 | Interventional Angiography System |
| Kerecis Limited | $151.22 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Thd America, INC. | $137.06 | 2021-2024 | |
| Tela Bio, INC. | $43.36 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ferring Pharmaceuticals INC. | $40.06 | 2019 | |
| Davol INC. | $32.34 | 2020 | |
| Baudax Bio INC. | $24.27 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.60 | 2020 | |
| Abbvie INC. | $18.69 | 2019 | |
| Coopersurgical, INC. | $16.11 | 2021 | |
| Braintree Laboratories, INC. | $13.34 | 2022 | |
| Ethicon US, LLC | $12.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$19,714.16 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.